C
CMND
vs
ATXS
ATXS
Over the past 12 months, CMND has underperformed ATXS, delivering a return of 0% compared to the ATXS's +89 718% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
ATXS
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
C
|
Clearmind Medicine Inc
CNSX:CMND
|
1.6
CAD
|
|||||
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
5 784.3
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
CMND, ATXS
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
C
|
Clearmind Medicine Inc
Revenue
|
|||||||||||
|
Astria Therapeutics Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
CMND, ATXS
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
C
|
Clearmind Medicine Inc
CNSX:CMND
|
|||||||||
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Clearmind Medicine Inc | ||||
|
Astria Therapeutics Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Clearmind Medicine Inc | ||||
|
Astria Therapeutics Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Clearmind Medicine Inc | ||||
|
Astria Therapeutics Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Clearmind Medicine Inc | ||||
|
Astria Therapeutics Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Clearmind Medicine Inc | ||||
|
Astria Therapeutics Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Clearmind Medicine Inc | ||||
|
Astria Therapeutics Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Clearmind Medicine Inc | ||||
|
Astria Therapeutics Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
C
|
Clearmind Medicine Inc | ||||
|
Astria Therapeutics Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
CMND, ATXS
Performance Gap
CMND, ATXS
Performance By Year
CMND, ATXS
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
|
| DE |
|
BioNTech SE
NASDAQ:BNTX
|
|
| US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|